메뉴 건너뛰기




Volumn 89, Issue 2, 2015, Pages 1058-1069

Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; MATRIX PROTEIN; PHOSPHOPROTEIN;

EID: 84920771788     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01850-14     Document Type: Article
Times cited : (25)

References (68)
  • 1
    • 67651085554 scopus 로고    scopus 로고
    • How we treat cytomegalovirus in hematopoietic cell transplant recipients
    • Boeckh M, Ljungman P. 2009. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 113:5711-5719. http://dx.doi.org/10.1182/blood-2008-10-143560.
    • (2009) Blood , vol.113 , pp. 5711-5719
    • Boeckh, M.1    Ljungman, P.2
  • 2
    • 79958148319 scopus 로고    scopus 로고
    • Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention
    • Flinsenberg TW, Compeer EB, Boelens JJ, Boes M. 2011. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin Exp Immunol 165:8-18. http://dx.doi.org/10.1111/j.1365-2249.2011.04411.x.
    • (2011) Clin Exp Immunol , vol.165 , pp. 8-18
    • Flinsenberg, T.W.1    Compeer, E.B.2    Boelens, J.J.3    Boes, M.4
  • 4
    • 0032555912 scopus 로고    scopus 로고
    • Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
    • Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188:1047-1054. http://dx.doi.org/10.1084/jem.188.6.1047.
    • (1998) J Exp Med , vol.188 , pp. 1047-1054
    • Polic, B.1    Hengel, H.2    Krmpotic, A.3    Trgovcich, J.4    Pavic, I.5    Luccaronin, P.6    Jonjic, S.7    Koszinowski, U.H.8
  • 5
    • 84865630094 scopus 로고    scopus 로고
    • Increasing the efficacy of tumor cell vaccines by enhancing cross priming
    • Andersen BM, Ohlfest JR. 2012. Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett 325:155-164. http://dx.doi.org/10.1016/j.canlet.2012.07.012.
    • (2012) Cancer Lett , vol.325 , pp. 155-164
    • Andersen, B.M.1    Ohlfest, J.R.2
  • 6
    • 84856702229 scopus 로고    scopus 로고
    • Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+T cells in seronegative donors
    • Loeth N, Assing K, Madsen HO, Vindelov L, Buus S, Stryhn A. 2012. Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+T cells in seronegative donors. PLoS One 7:e31420. http://dx.doi.org/10.1371/journal.pone.0031420.
    • (2012) PLoS One , vol.7
    • Loeth, N.1    Assing, K.2    Madsen, H.O.3    Vindelov, L.4    Buus, S.5    Stryhn, A.6
  • 8
    • 0032482337 scopus 로고    scopus 로고
    • A conditioned dendritic cell can be a temporal bridge between a CD4+T-helper and a T-killer cell
    • Ridge JP, Di Rosa F, Matzinger P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+T-helper and a T-killer cell. Nature 393:474-478. http://dx.doi.org/10.1038/30989.
    • (1998) Nature , vol.393 , pp. 474-478
    • Ridge, J.P.1    Di Rosa, F.2    Matzinger, P.3
  • 9
    • 0032482474 scopus 로고    scopus 로고
    • T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
    • Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483. http://dx.doi.org/10.1038/31002.
    • (1998) Nature , vol.393 , pp. 480-483
    • Schoenberger, S.P.1    Toes, R.E.2    van der Voort, E.I.3    Offringa, R.4    Melief, C.J.5
  • 11
    • 0030848161 scopus 로고    scopus 로고
    • Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
    • Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186:65-70. http://dx.doi.org/10.1084/jem.186.1.65.
    • (1997) J Exp Med , vol.186 , pp. 65-70
    • Bennett, S.R.1    Carbone, F.R.2    Karamalis, F.3    Miller, J.F.4    Heath, W.R.5
  • 12
    • 0020077493 scopus 로고
    • Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
    • Keene JA, Forman J. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 155:768-782. http://dx.doi.org/10.1084/jem.155.3.768.
    • (1982) J Exp Med , vol.155 , pp. 768-782
    • Keene, J.A.1    Forman, J.2
  • 13
    • 79954579274 scopus 로고    scopus 로고
    • Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody
    • Fransen MF, Sluijter M, Morreau H, Arens R, Melief CJ. 2011. Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody. Clin Cancer Res 17:2270-2280. http://dx.doi.org/10.1158/1078-0432.CCR-10-2888.
    • (2011) Clin Cancer Res , vol.17 , pp. 2270-2280
    • Fransen, M.F.1    Sluijter, M.2    Morreau, H.3    Arens, R.4    Melief, C.J.5
  • 18
    • 84881028899 scopus 로고    scopus 로고
    • Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients
    • Clari MA, Aguilar G, Benet I, Belda J, Gimenez E, Bravo D, Carbonell JA, Henae L, Navarro D. 2013. Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. J Med Virol 85:1802-1810. http://dx.doi.org/10.1002/jmv.23621.
    • (2013) J Med Virol , vol.85 , pp. 1802-1810
    • Clari, M.A.1    Aguilar, G.2    Benet, I.3    Belda, J.4    Gimenez, E.5    Bravo, D.6    Carbonell, J.A.7    Henae, L.8    Navarro, D.9
  • 20
  • 22
    • 82355184177 scopus 로고    scopus 로고
    • Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR
    • Unit 10.33
    • Quigley MF, Almeida JR, Price DA, Douek DC. 2011. Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR. Curr Protoc Immunol Chapter 10:Unit 10.33. http://dx.doi.org/10.1002/0471142735.im1033s94.
    • (2011) Curr Protoc Immunol Chapter , vol.10
    • Quigley, M.F.1    Almeida, J.R.2    Price, D.A.3    Douek, D.C.4
  • 23
    • 79958045471 scopus 로고    scopus 로고
    • IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences
    • Giudicelli V, Brochet X, Lefranc MP. 2011. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc 2011:695-715. http://dx.doi.org/10.1101/pdb.prot5633.
    • (2011) Cold Spring Harb Protoc , vol.2011 , pp. 695-715
    • Giudicelli, V.1    Brochet, X.2    Lefranc, M.P.3
  • 25
    • 84871499801 scopus 로고    scopus 로고
    • Fcgamma receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells
    • Flinsenberg TW, Compeer EB, Koning D, Klein M, Amelung FJ, van Baarle D, Boelens JJ, Boes M. 2012. Fcgamma receptor antigen targeting potentiates cross-presentation by human blood and lymphoid tissue BDCA-3+ dendritic cells. Blood 120:5163-5172. http://dx.doi.org/10.1182/blood-2012-06-434498.
    • (2012) Blood , vol.120 , pp. 5163-5172
    • Flinsenberg, T.W.1    Compeer, E.B.2    Koning, D.3    Klein, M.4    Amelung, F.J.5    van Baarle, D.6    Boelens, J.J.7    Boes, M.8
  • 27
    • 1542514777 scopus 로고    scopus 로고
    • Myeloid differentiation factor 88 is required for cross-priming in vivo
    • Palliser D, Ploegh H, Boes M. 2004. Myeloid differentiation factor 88 is required for cross-priming in vivo. J Immunol 172:3415-3421. http://dx.doi.org/10.4049/jimmunol.172.6.3415.
    • (2004) J Immunol , vol.172 , pp. 3415-3421
    • Palliser, D.1    Ploegh, H.2    Boes, M.3
  • 28
    • 34248147607 scopus 로고    scopus 로고
    • Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
    • de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. 2007. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66:589-598. http://dx.doi.org/10.1136/ard.2006.061853.
    • (2007) Ann Rheum Dis , vol.66 , pp. 589-598
    • de Jager, W.1    Hoppenreijs, E.P.2    Wulffraat, N.M.3    Wedderburn, L.R.4    Kuis, W.5    Prakken, B.J.6
  • 31
    • 0027971622 scopus 로고
    • CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
    • Matloubian M, Concepcion RJ, Ahmed R. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68:8056-8063.
    • (1994) J Virol , vol.68 , pp. 8056-8063
    • Matloubian, M.1    Concepcion, R.J.2    Ahmed, R.3
  • 32
    • 70849099812 scopus 로고    scopus 로고
    • CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help
    • Nakanishi Y, Lu B, Gerard C, Iwasaki A. 2009. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462:510-513. http://dx.doi.org/10.1038/nature08511.
    • (2009) Nature , vol.462 , pp. 510-513
    • Nakanishi, Y.1    Lu, B.2    Gerard, C.3    Iwasaki, A.4
  • 36
    • 17744418516 scopus 로고    scopus 로고
    • CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity
    • Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJ. 1998. CD40-CD40 ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol 10:443-448. http://dx.doi.org/10.1006/smim.1998.0147.
    • (1998) Semin Immunol , vol.10 , pp. 443-448
    • Toes, R.E.1    Schoenberger, S.P.2    van der Voort, E.I.3    Offringa, R.4    Melief, C.J.5
  • 38
    • 2142730100 scopus 로고    scopus 로고
    • Central memory and effector memory T cell subsets: function, generation, and maintenance
    • Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745-763. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104702.
    • (2004) Annu Rev Immunol , vol.22 , pp. 745-763
    • Sallusto, F.1    Geginat, J.2    Lanzavecchia, A.3
  • 39
    • 84878510652 scopus 로고    scopus 로고
    • Extracellular domains of CD8alpha and CD8ss subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells
    • van Loenen MM, Hagedoorn RS, de Boer R, Falkenburg JH, Heemskerk MH. 2013. Extracellular domains of CD8alpha and CD8ss subunits are sufficient for HLA class I restricted helper functions of TCR-engineered CD4(+) T cells. PLoS One 8:e65212. http://dx.doi.org/10.1371/journal.pone.0065212.
    • (2013) PLoS One , vol.8
    • van Loenen, M.M.1    Hagedoorn, R.S.2    de Boer, R.3    Falkenburg, J.H.4    Heemskerk, M.H.5
  • 40
    • 84875463042 scopus 로고    scopus 로고
    • Molecular mechanisms of T cell co-stimulation and co-inhibition
    • Chen L, Flies DB. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227-242. http://dx.doi.org/10.1038/nri3405.
    • (2013) Nat Rev Immunol , vol.13 , pp. 227-242
    • Chen, L.1    Flies, D.B.2
  • 41
    • 84879978005 scopus 로고    scopus 로고
    • Abatacept: a review of its use in the management of rheumatoid arthritis
    • Keating GM. 2013. Abatacept: a review of its use in the management of rheumatoid arthritis. Drugs 73:1095-1119. http://dx.doi.org/10.1007/s40265-013-0080-9.
    • (2013) Drugs , vol.73 , pp. 1095-1119
    • Keating, G.M.1
  • 42
    • 84875687447 scopus 로고    scopus 로고
    • Biologic therapy for autoimmune diseases: an update
    • Rosman Z, Shoenfeld Y, Zandman-Goddard G. 2013. Biologic therapy for autoimmune diseases: an update. BMC Med 11:88. http://dx.doi.org/10.1186/1741-7015-11-88.
    • (2013) BMC Med , vol.11 , pp. 88
    • Rosman, Z.1    Shoenfeld, Y.2    Zandman-Goddard, G.3
  • 43
    • 84892403706 scopus 로고    scopus 로고
    • CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses
    • Harfuddin Z, Kwajah S, Chong Nyi Sim A, Macary PA, Schwarz H. 2013. CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses. Oncoimmunology 2:e26859. http://dx.doi.org/10.4161/onci.26859.
    • (2013) Oncoimmunology , vol.2
    • Harfuddin, Z.1    Kwajah, S.2    Chong Nyi Sim, A.3    Macary, P.A.4    Schwarz, H.5
  • 45
    • 58149165364 scopus 로고    scopus 로고
    • Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies
    • Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D, Kapoor N, Guinan EC, Feig SA, Wagner EL, Kernan NA. 2008. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 112:4318-4327. http://dx.doi.org/10.1182/blood-2007-06-098020.
    • (2008) Blood , vol.112 , pp. 4318-4327
    • Kurtzberg, J.1    Prasad, V.K.2    Carter, S.L.3    Wagner, J.E.4    Baxter-Lowe, L.A.5    Wall, D.6    Kapoor, N.7    Guinan, E.C.8    Feig, S.A.9    Wagner, E.L.10    Kernan, N.A.11
  • 47
    • 84893792563 scopus 로고    scopus 로고
    • EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoietic SCT
    • Rasche L, Kapp M, Einsele H, Mielke S. 2014. EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoietic SCT. Bone Marrow Transplant 49:163-167. http://dx.doi.org/10.1038/bmt.2013.96.
    • (2014) Bone Marrow Transplant , vol.49 , pp. 163-167
    • Rasche, L.1    Kapp, M.2    Einsele, H.3    Mielke, S.4
  • 49
    • 48949118491 scopus 로고    scopus 로고
    • Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation
    • Vandenbosch K, Ovetchkine P, Champagne MA, Haddad E, Alexandrov L, Duval M. 2008. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation. Biol Blood Marrow Transplant 14:867-871. http://dx.doi.org/10.1016/j.bbmt.2008.05.006.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 867-871
    • Vandenbosch, K.1    Ovetchkine, P.2    Champagne, M.A.3    Haddad, E.4    Alexandrov, L.5    Duval, M.6
  • 50
    • 0037112446 scopus 로고    scopus 로고
    • Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell
    • Gao FG, Khammanivong V, Liu WJ, Leggatt GR, Frazer IH, Fernando GJ. 2002. Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. Cancer Res 62:6438-6441. http://cancerres.aacrjournals.org/content/62/22/6438.long.
    • (2002) Cancer Res , vol.62 , pp. 6438-6441
    • Gao, F.G.1    Khammanivong, V.2    Liu, W.J.3    Leggatt, G.R.4    Frazer, I.H.5    Fernando, G.J.6
  • 51
    • 0034666095 scopus 로고    scopus 로고
    • Importance of CD4(+) T helper cell responses in tumor immunity
    • Ossendorp F, Toes RE, Offringa R, van der Burg SH, Melief CJ. 2000. Importance of CD4(+) T helper cell responses in tumor immunity. Immunol Lett 74:75-79. http://dx.doi.org/10.1016/S0165-2478(00)00252-2.
    • (2000) Immunol Lett , vol.74 , pp. 75-79
    • Ossendorp, F.1    Toes, R.E.2    Offringa, R.3    van der Burg, S.H.4    Melief, C.J.5
  • 52
    • 0037432776 scopus 로고    scopus 로고
    • Defective CD8 T cell memory following acute infection without CD4 T cell help
    • Sun JC, Bevan MJ. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-342. http://dx.doi.org/10.1126/science.1083317.
    • (2003) Science , vol.300 , pp. 339-342
    • Sun, J.C.1    Bevan, M.J.2
  • 53
    • 4644271443 scopus 로고    scopus 로고
    • CD4+T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
    • Sun JC, Williams MA, Bevan MJ. 2004. CD4+T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5:927-933. http://dx.doi.org/10.1038/ni1105.
    • (2004) Nat Immunol , vol.5 , pp. 927-933
    • Sun, J.C.1    Williams, M.A.2    Bevan, M.J.3
  • 54
    • 37349117338 scopus 로고    scopus 로고
    • Immune reconstitution in children after unrelated cord blood transplantation
    • Szabolcs P, Niedzwiecki D. 2008. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 14:66-72. http://dx.doi.org/10.1016/j.bbmt.2007.10.016.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 66-72
    • Szabolcs, P.1    Niedzwiecki, D.2
  • 56
    • 0032482274 scopus 로고    scopus 로고
    • Immunology. Licence to kill
    • Lanzavecchia A. 1998. Immunology. Licence to kill. Nature 393:413-414. http://dx.doi.org/10.1038/30845.
    • (1998) Nature , vol.393 , pp. 413-414
    • Lanzavecchia, A.1
  • 59
    • 0035282725 scopus 로고    scopus 로고
    • Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
    • Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J, Goldman J, Craddock C, Moss PA. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97:1232-1240. http://dx.doi.org/10.1182/blood.V97.5.1232.
    • (2001) Blood , vol.97 , pp. 1232-1240
    • Cwynarski, K.1    Ainsworth, J.2    Cobbold, M.3    Wagner, S.4    Mahendra, P.5    Apperley, J.6    Goldman, J.7    Craddock, C.8    Moss, P.A.9
  • 60
    • 0032418812 scopus 로고    scopus 로고
    • The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
    • Kalams SA, Walker BD. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188:2199-2204. http://dx.doi.org/10.1084/jem.188.12.2199.
    • (1998) J Exp Med , vol.188 , pp. 2199-2204
    • Kalams, S.A.1    Walker, B.D.2
  • 61
    • 9644259300 scopus 로고    scopus 로고
    • Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
    • Gandhi MK, Khanna R. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4:725-738. http://dx.doi.org/10.1016/S1473-3099(04)01202-2.
    • (2004) Lancet Infect Dis , vol.4 , pp. 725-738
    • Gandhi, M.K.1    Khanna, R.2
  • 63
    • 77952724358 scopus 로고    scopus 로고
    • Cytomegalovirus in hematopoietic stem cell transplant recipients
    • Ljungman P, Hakki M, Boeckh M. 2010. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am 24:319-337. http://dx.doi.org/10.1016/j.idc.2010.01.008.
    • (2010) Infect Dis Clin North Am , vol.24 , pp. 319-337
    • Ljungman, P.1    Hakki, M.2    Boeckh, M.3
  • 65
    • 77955942421 scopus 로고    scopus 로고
    • Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMVreactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy
    • George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K. 2010. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMVreactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis 12: 322-329. http://dx.doi.org/10.1111/j.1399-3062.2010.00504.x.
    • (2010) Transpl Infect Dis , vol.12 , pp. 322-329
    • George, B.1    Pati, N.2    Gilroy, N.3    Ratnamohan, M.4    Huang, G.5    Kerridge, I.6    Hertzberg, M.7    Gottlieb, D.8    Bradstock, K.9
  • 66
    • 77958541970 scopus 로고    scopus 로고
    • Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation
    • Jaskula E, Dlubek D, Sedzimirska M, Duda D, Tarnowska A, Lange A. 2010. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. Transplant Proc 42:3273-3276. http://dx.doi.org/10.1016/j.transproceed.2010.07.027.
    • (2010) Transplant Proc , vol.42 , pp. 3273-3276
    • Jaskula, E.1    Dlubek, D.2    Sedzimirska, M.3    Duda, D.4    Tarnowska, A.5    Lange, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.